New member to Active board

The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be ...

Fosterdiagnoser ökar markant

Andelen medfödda hjärtfel som upptäcks redan under fosterstadiet har ökat markant i Sverige.

Swedish top scientists to EMBO

Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...

Researchers goes to the bottom of the brain

Swedish researchers have recently got new and deeper knowledge about the smallest part of the brain, the granule cells.

How to get visitors to your booth

Food, ball throwing and laser engraved pens. There are many tricks to attract visitors to the stands at Scanlab.

Synact Pharma mot notering

Bioteknikbolaget genomför emission och siktar på Aktietorget i juli.

Utökar marknadsandelar

Efter satsningar på säljarbetet meddelar Orexo att bolagets produkter växer på marknaden.

Welcome to wonderful Copenhagen

Strategically located, the Danish capital is the focal point of one of the most dynamic regions in Northern Europe. Here are some tips on where to spend your ti...

Fat cells' reaction differs with body weight

The fat cells of overweight people may react differently to dietary changes than in their lean peers, according to a pioneering study from the Dutch organizatio...

Major changes to the Q-Med board

The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.

Crafoord Prize to an American and two Japanese

Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.

We are poor lobbyists

I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.

An industry emerging from crisis

"Scanlab is normally indicative of the status of investment incentives in the laboratory industry "

Crestor-kopior ger minskade intäkter

AstraZenecas försäljning minskar efter utgången av Crestor-patentet.

Open innovation ökar chanserna

Open innovation-samarbeten tredubblar chanserna för utvecklingen av läkemedel att lyckas, enligt en ny rapport.

En snyggare Biotechsweden.se

How to get the most out of the fair

Nordisk Produktchef IPSEN

Satsar på sälj

Efter ett utökat antal godkända doser av Zubsolv under det fjärde kvartalet stärker Orexo sitt fokus på försäljning och letar efter en partner utanför USA.

Sverige drunknar i Pfizers planer

När läkemedelsjätten leker med tanken på att köpa upp Astrazeneca ligger fokus inte på Sverige.

New tools to fight bacteria

Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...

Martin Bergö: "The Idea is the Thing"

Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...

Framåt för Zubsolv

Efter ett händelserikt tredje kvartal visar Orexo upp ett minskat resultat men en ökad nettoomsättning för Zubsolv i USA.

Många medicinska studier publiceras aldrig

Mer än varannan av de läkemedelsstudier som görs i USA är opublicerad 30 månader efter att de avslutats, visar en ny genomgång.